Influence of C677T Polymorphism of 5,10-Methylenetetrahydrofolate Reductase on Methotrexate Toxicity

YAN Xu-yan,XU Dong-hang

DOI: https://doi.org/10.3321/j.issn:1001-2494.2007.01.020

2007-01-01

Abstract:OBJECTIVE To investigate the relationship between the mutation of 5,10-methylenetetrahydro-folate reductase(MTHFR) gene 677 C→T and the adverse drug reaction of methotrexate(MTX) in patients with rheumatoid arthritis((RA).)METHODS A total of 210 patients with RA were divided into MTX group,MTX+sulphasalazine(SASP) group,MTX+ Leflunomide(LEF) group and LEF+SASP group.100 healthy subjects were chosed as control group. PCR-restrictive fragment length polymorphism(RFLP) analysis was conducted to test mutation.The clinical measurements,laboratory measurements,the Disease Activity Score(DAS) were evaluated during 48 weeks.And the cases of adverse drug reaction(ADR) were also collected.RESULTS No difference was tained the three with genotypes of MTHFR.The frequencies of adverse drug reaction of patients with heterozygous(CT),and homozygous(TT) mutation in MTX,MTX+SASP,MTX+LEF was more than that without mutation(CC).Patients with heterozygous or homozygous mutation in the MTHFR gene induced a significantly higher plasma homocysteine at week 48,compared with those without mutation.But there was no statistical significance observed amonc CT,TT and CC when in LEF+SASP group.CONCLUSION MTHFR gene C677T mutation is probably one of the genetic risk factors for adverse drug reaction of MTX.